• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:司鸽,郭建艳,张红贞,高娟,郑忠辉.盐酸西替利嗪片人体生物等效性试验[J].药学研究,2020,39(9):520-524[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2932次   下载 2757次 本文二维码信息
码上扫一扫!
盐酸西替利嗪片人体生物等效性试验
司鸽1,郭建艳2,张红贞2,高娟3,郑忠辉2
字体:加大+|默认|缩小-
(1.淄博职业学院,山东 淄博 255314;2.山东新华制药股份有限公司,山东 淄博 255035;3.山东药品食品职业学院基础教学部,山东 淄博 255011)
摘要:
目的 评价健康受试者空腹和餐后条件下单剂量服用盐酸西替利嗪片受试制剂和参比制剂是否具有生物等效性。方法 采用随机、开放、单剂量、自身交叉设计,液质联用(LC-MS/MS)法测定健康受试者空腹或餐后给药后血浆中西替利嗪的药物浓度,使用Phoenix Winnonlin 8.0软件计算药动学参数,使用SAS 9.4软件进行生物等效性评价。结果 空腹BE试验:24名健康受试者分别单次空腹服用受试制剂和参比制剂10 mg后,Cmax、AUC0-t、AUC0-∞几何均数的比值分别为100.18%、96.37%、96.00%,其90%置信区间分别为95.72% ~ 14.84%、92.37% ~ 100.55%、91.77% ~ 100.42%,均落在等效区间80.00% ~ 125.00%之间;餐后BE试验:22名健康受试者分别单次餐后服用受试制剂和参比制剂10 mg后,Cmax、AUC0-t、AUC0-∞几何均数的比值分别为103.98%、102.19%、101.58%,其90%置信区间分别为98.31% ~ 109.97%、98.33% ~ 106.20%、98.07% ~ 105.20%,均落在等效区间80.00% ~ 125.00%之间。结论 两种制剂对于空腹和餐后条件下的健康成年受试者具有生物等效性。
关键词:  西替利嗪  生物等效性试验  药代动力学
DOI:10.13506/j.cnki.jpr.2020.09.006
基金项目:
Bioequivalence tests of Cetirizine Hydrochloride Teblets in healthy volunteers
SI Ge1,GUO Jianyan2,ZHANG Honghen2,GAO Juan3,ZHENG Zhonghui2
(Cetirizine; Bioequivalence; Pharmacokinetic)
Abstract:
Objective To evaluate the bioequivalence of preparations and reference subjects in a single dose of cetirizine hydrochloride tablets under fasting and postprandial conditions in healthy volunteers.Methods A random, open label, single-dose, self-crossover test was designed. LC-MS/MS was applied to determine the concentration of cetirizine in plasma of healthy subjects after fasting or postprandial administration, while PHOENIX WINNONLIN 8.0 and SAS 9.4 software were used for pharmacokinetics (PK) parameters calculation and bioequivalence analysis, respectively.Results In the fast test, 24 healthy subjects took the test preparation and the reference preparation 10 mg on a single fasting. The ratio of the geometric mean of Cmax, AUC0-t, AUC0-∞ are 100.18%, 96.37%, 96.00%, respectively. The 90% confidence intervals of Cmax, AUC0-t, AUC0-∞ are 95.72% ~ 14.84%, 92.37% ~ 100.55%, 91.77% ~ 100.42%, respectively. All these data are falling within the equivalent interval of 80.00% ~ 125.00%. In the postprandial test, 22 healthy subjects took the test and reference preparations 10 mg after a single meal. The ratio of the geometric mean of Cmax, AUC0-t, AUC0-∞ are 103.98%, 102.19% 101.58%, respectively, with 90% confidence intervals of 98.31% ~ 109.97%, 98.33% ~ 106.20%, 98.07% ~ 105.20%, respectively, all of which are falling within the equivalent range of 80.00% ~ 125.00%.Conclusion The two formulations are bioequivalent to healthy adult volunteers under fasting and postprandial conditions.
Key words:  Cetirizine  Bioequivalence  Pharmacokinetic
今日访问量:2329    总访问量:55338697
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司